Roxburgh, Amanda Nielsen, Suzanne
Published in
The International journal on drug policy
Increasing overdose deaths attributable to illicitly manufactured fentanyl and fentanyl analogues in North America has driven international concern about the expansion of these substances into drug markets elsewhere. This paper investigates 20-year trends in fentanyl deaths in Australia, distinguishing between deaths attributable to pharmaceutical,...
Picco, Louisa Sanfilippo, Paul Xia, Ting Lam, Tina Nielsen, Suzanne
Published in
The International journal on drug policy
Prescription drug monitoring programs (PDMP) are electronic databases that track the prescribing and dispensing of high-risk medicines such as opioids. They have the ability to provide clinicians with alerts, which identify medication-related risks, and are used to help inform decisions to supply. This study aimed to determine to what extent patien...
Zigon, Jarrett Vitellone, Nicole Duff, Cameron Theodoropoulou, Lena
Published in
The International journal on drug policy
Weinberg, Darin
Published in
The International journal on drug policy
Addiction science is very often cast as an indispensable source of political justification and clinical resources for engaging addicts therapeutically rather than punitively. It is said to promote an image of overcoming addictions as projects of recovery from disease or mental disorder rather than merely a repudiation of one's formerly troubled way...
Szymanski, Adam
Published in
The International journal on drug policy
This essay presents three film examples from across the cinemas of Canada which grapple with the politics of sobriety amidst unique cultural contexts: Werewolf (Ashley McKenzie, 2016) broaches the topic of opioid addiction on Cape Breton Island; Love in the Time of Civil War (Rodrigue Jean, 2014) of drug addiction on the streets of Montreal; and Th...
Vitellone, Nicole Theodoropoulou, Lena Manchot, Melanie
Published in
The International journal on drug policy
This article investigates the methodological potential of interdisciplinary research to generate collective rather than interpretive or reflective knowledge practices for the study of recovery from addiction to drugs and alcohol. The question that informs this investigation of knowledge practices is how researchers participate in knowledge producti...
Ruiz, Ana Saavedra Fontaine, Guillaume Patey, Andrea M Grimshaw, Jeremy M Presseau, Justin Cox, Joseph Dussault, Camille Kronfli, Nadine
Published in
The International journal on drug policy
Diffuse implementation of hepatitis C virus (HCV) treatment is dependent on universal screening for HCV, but screening strategies are heterogenous across prisons in the province of Quebec (Canada). We sought to identify barriers and enablers to universal opt-out HCV screening and to describe the multisectoral decision-making processes related to HC...
Textor, Lauren Ventricelli, Daniel Aronowitz, Shoshana V
Published in
The International journal on drug policy
Structural vulnerabilities for people who use drugs (PWUD) were exacerbated by the COVID-19 pandemic. In this context, federal lawmakers in the United States (U.S.) invoked an exemption to the 2008 Ryan Haight Act requiring in-person evaluation to prescribe buprenorphine for treatment of opioid use disorder (OUD), which allowed for the initiation a...
Beaulac, Melissa Richardson, Lindsey Tobias, Samuel Lysyshyn, Mark Grant, Cameron Ti, Lianping
Published in
The International journal on drug policy
Increased drug-related harms, including overdoses (poisonings), have been reported in the days around income assistance payments, yet little is known about changes in the unregulated drug supply during this time. In this exploratory analysis, we investigated whether changes in the unregulated opioid drug supply are associated with income assistance...
Muller, Abbe Akiyama, Matthew J Riback, Lindsey Nyakowa, Mercy Musyoki, Helgar Cherutich, Peter Kurth, Ann
Published in
The International journal on drug policy
People who inject drugs are at an increased risk for contracting SARS-CoV-2 and have experienced barriers to accessing harm reduction services during the COVID-19 pandemic. Understanding how to best provide these services is essential for COVID-19 mitigation. The goal of this study was to ascertain challenges and successes for caring for people who...
